Feb. 22 at 9:22 PM
$RLFTF $NRXP Oh cool. I either missed that or already forgot it. Last year a trial of Centurion Pharma (they once hat a collab with a predecessor company of Relief) came to the conclusion "that inhaled aviptadil is well tolerated and can be used as a supplementary intervention to fasten the recovery of respiratory manifestations in hospitalized patients for COVID-19 pneumonia.": https://doi.org/10.1159/000543773
Shame on you greedy motherfuckers for not working together back then to get this drug approved. Fame and glory would have been yours for sure, patients would have benefited, and we would have been happy too. And yeah, I'm still not over it. That crap works in nearly every study except Javitt's, because we wanted to revive the deadest of the dead. Grrrr....
